Just been looking at Lam Research's recent numbers and there's something pretty interesting happening in the foundry equipment space. LRCX just posted their second quarter with revenues hitting $5.34 billion - that's 22% growth year-over-year. More notably, their Systems segment jumped 28%, and here's the kicker: foundry business went from 35% of Systems sales to 59% in just one year.



Why does this matter? The AI chip manufacturing boom is real. Everyone's scrambling to build capacity for advanced chips, and Lam Research is sitting in a sweet spot with their etch and deposition tools. Their new tech like the Aether EUV patterning solution is gaining serious traction with the big chipmakers. These tools are essential for pushing toward next-gen nodes and handling the complexity that comes with it.

Looking ahead, analysts are projecting Q3 Systems revenues around $3.7 billion with roughly 22% growth. Total revenue expectations sit around $5.74 billion. That's pretty solid momentum if it holds.

Of course, they've got competition. Applied Materials and KLA are both strong players in this space - AMAT competes directly on deposition and etch, while KLA dominates process control and inspection. But LRCX's foundry exposure seems to be the real differentiator right now.

Valuation-wise, LRCX is trading at a 39.75 forward P/E, which is notably higher than the semiconductor industry average of 32.07. The earnings growth projections for fiscal 2026 and 2027 are around 27% and 26% respectively, so the market is pricing in continued strength. Stock's already up over 200% in the past year compared to the broader semiconductor sector's 50% gain.

The foundry equipment space looks like it's got real legs given where AI manufacturing is heading. Whether LRCX can maintain this revenue streak probably comes down to whether the foundry investment cycle keeps accelerating.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin